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Fig 1. 30-day freedom from major amputations after infrainguinal endo-
vascular interventions with and without IVUS.
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1112 Abstracts October 2014Objectives: Advancements in endovascular therapy have made the
minimally invasive repair of juxtarenal and thoracoabdominal aneurysms a
possibility. Comparison of long-term results of endovascular repair (ER)
vs open repair (OR) of thoracoabdominal aneurysms is required to deter-
mine the most appropriate treatment options.
Methods: The Inpatient Medicare database from 2004 to 2011 was
investigated using International Classiﬁcation of Diseases, 9th Revision pro-
cedure codes for repair of abdominal, thoracic, and thoracoabdominal aortic
aneurysms with associated concomitant renal or mesenteric revasculariza-
tion for OR and ER. Fenestrated endovascular grafting codes were used
once available in 2011. Demographics, preoperative comorbidities, mortal-
ities, and postoperative complications were analyzed using the t-test for
continuous and the c2 test for categoric variables. Kaplan-Meier curves
and multivariable Cox models were used to estimate effect of treatment
on survival.
Results: A total of 4749 patients met inclusion criterion: 3757 OR
and 992 ER groups. The 30-day mortality was signiﬁcantly less after ER
(mean mortality: 12.3 for OR vs 8.2 for ER; P < .001). Patients after
OR had higher rates of renal failure (15.3% vs 9.4%) and cardiac (4.5%
vs 2.3%) and pulmonary insufﬁciency (11.5% vs3.6%). ER patients had
higher rates of peripheral vascular (1.8% vs 1%) and device malfunction
(6.9% vs 1.1%) complications. Although survival up to almost 2 years was
better after ER, survival curves converged after 21 months of follow-up
(Fig 1). Propensity-matched patients conﬁrmed a 2-year advantage for
ER over OR (Fig 2).
Conclusions: Like ER of abdominal aortic aneurysm, ER of thora-
coabdominal and juxtarenal aneurysms has a distinct 2-year advantage
but then becomes not statistically different at up to 7 years of follow-
up. This may reﬂect the prevalence of other comorbidities resulting in
late mortality in both groups. This preliminary study based on national re-
sults does support more in-depth long-term prospective analysis, especially
as techniques for thoracoabdominal repair become more standardized and
widespread.
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Objectives: Angiography alone may underestimate lower extremity
(LE) arterial disease burden. Intravascular ultrasound (IVUS) as an adjunc-
tive tool has been theorized to improve patency and lessen secondary pro-
cedures. We identiﬁed IVUS use for LE endovascular procedures to assess
outcomes.
Methods: Medicare beneﬁciaries undergoing infrainguinal endovas-
cular interventions with IVUS were identiﬁed from 2005 to 2009 MedPAR
and Carrier ﬁles using Current Procedural Terminology codes. Patients
were matched 1:2 to patients not receiving IVUS by a propensity score
based on age, gender, race, and comorbidities. The c2 test, Wilcoxon
rank sum test, Kaplan-Meier survival analysis, and Cox proportional hazards
modeling were used.
Results: A total of 1362 patients undergoing LE intervention with
IVUS were matched to 2724 patients not receiving IVUS. Mean age was
75 years, 52.6% were men, and 79.1% were white. The most common
indications were claudication (29.6%) and ulceration/gangrene (25.9%).
No differences in complications for IVUS vs non-IVUS, respectively,
were identiﬁed: cardiac (2.3% vs 2.4%; P ¼ .9), renal (6.8% vs 7.9%; P
¼ .2), bleeding (8.3% vs 8.2%; P ¼ .9), and embolism or thrombosis
(6.4% vs 7.9%; P ¼ .08). Total charges ($73,516 vs $69,221; P ¼
.046) and supply costs ($23,644 vs $15,322; P < .0001) were signiﬁ-
cantly higher with IVUS. The 30-day above-knee (1.8% vs 1.4%; P ¼
.4) and below-knee (3.2% vs 3.1%; P ¼ .9) amputation rates did not
differ between IVUS and non-IVUS, respectively (Fig 1). The 30-day
rates of repeat angioplasty (9.6% vs 8.7; P ¼ .3) and embolectomy
(1.3% vs 1.6%; P ¼ .4) did not differ, whereas rates of stenting (7.5%
vs 5.5%; P ¼ .01) and thrombolysis (3.4% vs 1.3%; P < .0001) were
higher for IVUS. Modeling demonstrated that IVUS use was not associ-
ated with reduced amputation rates (hazard ratio [HR], 1.03; 95% con-
ﬁdence interval [CI], 0.76-1.4), whereas black race (HR, 1.58; 95% CI,
1.12-2.23), renal failure (HR, 1.82; 95% CI, 1.30-2.56), and disease
severity were associated with amputation.
Conclusions: As an adjunctive tool during infrainguinal interven-
tions, IVUS was not associated with improved 30-day major amputa-
tion but was more frequently associated with thrombolysis andstenting. Total charges and supply costs were signiﬁcantly greater
with IVUS, suggesting that IVUS does not improve outcomes while
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Objectives: This study assessed aortic arch morphology and aortic
length in patients with dissection, traumatic injury, and aneurysm undergo-
ing thoracic endovascular aortic repair and identiﬁed characteristics speciﬁc
to the different pathologies.
Methods: We retrospectively evaluated the aortic arch
morphology and aortic length of 210 patients (49 dissection, 99 trau-
matic injury, 62 aneurysm) enrolled in three trials who received the
conformable Gore TAG thoracic endoprosthesis. The mean age was
43 6 19.6 years for trauma patients, 57 6 11.7 years for dissection
patients, and 72 6 9.6 years for aneurysm patients. A standardized
protocol was used to measure aortic arch diameter, length, and take-
off angle, and clock-face orientation of branch vessels. Differences in
arch anatomy and length were assessed using analysis of variance and
independent t-tests.
Results: Of the 210 arches evaluated, 22% had arch vessel com-
mon trunk conﬁgurations. The Table contains highlights of compre-
hensive measurements. The aortic diameter and the distance from
the left main coronary to the left common carotid were greater in
dissection patients than in trauma or aneurysm patients (P < .05).
The distances from the branch vessels to the celiac artery were greater
in dissection and aneurysm patients than in trauma patients (P < .05).
Aortic diameter was greater in aneurysm patients compared with
trauma patients (P < .05). The take-off angle of the innominate,
left common carotid, and left subclavian were greater, between 19%
and 36%, in trauma patients than in dissection and aneurysm patients
(P < .05). Clock-face orientation of the arch vessels varied between
pathologies.
Conclusions: Arch anatomy has signiﬁcant morphologic differ-
ences when comparing aortic pathologies. Describing these differences
in a large sample of patients is beneﬁcial for device designs and pa-
tient selection that plays a critical role in outcomes.
